Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Myelodysplastic Syndromes 107Leukemia, Myeloid, Acute 101Precursor Cell Lymphoblastic Leukemia-Lymphoma 85Hodgkin Disease 65Lymphoma, Non-Hodgkin 64Leukemia, Lymphocytic, Chronic, B-Cell 63Leukemia, Myelogenous, Chronic, BCR-ABL Positive 59Multiple Myeloma 57Myeloproliferative Disorders 55Leukemia 52Lymphoma, Mantle-Cell 46Lymphoma, Follicular 44Lymphoma, B-Cell, Marginal Zone 41Leukemia, Myelomonocytic, Chronic 41Lymphoma 38Burkitt Lymphoma 38Lymphoma, Large B-Cell, Diffuse 33Primary Myelofibrosis 32Leukemia, Biphenotypic, Acute 30Congenital Abnormalities 30Leukemia, Myeloid, Chronic-Phase 29Leukemia, Myeloid, Accelerated Phase 29Lymphoma, Large-Cell, Immunoblastic 26Blast Crisis 25Anemia, Refractory, with Excess of Blasts 25Waldenstrom Macroglobulinemia 23Dendritic Cell Sarcoma, Interdigitating 22Lymphoma, Large-Cell, Anaplastic 21Lymphoma, T-Cell, Cutaneous 20Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 19

Interventions

liposomal amphotericin B 2Voriconazole 2Polymerase Chain Reaction 2Pentetic Acid 2Moxifloxacin 2Itraconazole 2Fluconazole 2Caspofungin 2fludarabine phosphate 1ethanolamine oleate 1amphotericin B, deoxycholate drug combination 1Whole-Body Irradiation 1Watchful Waiting 1Vancomycin 1Valacyclovir 1Trimethoprim, Sulfamethoxazole Drug Combination 1Trimethoprim 1Therapeutics 1Tazobactam 1Tacrolimus 1Sulfamethoxazole 1Sodium Chloride 1Sirolimus 1Saline Solution, Hypertonic 1Saline Solution 1Ribavirin 1Piperacillin, Tazobactam Drug Combination 1Piperacillin 1Peripheral Blood Stem Cell Transplantation 1Palivizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × Whole-Body Irradiation × Myeloid × Clear all
NCT00589563 2014-09-10

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

City of Hope Medical Center

Phase 2 Completed
32 enrolled 24 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Precancerous Conditions, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡